Ionis Pharmaceuticals Down 26%, On Pace For Largest Percent Decrease Since May 2016 -- Data Talk
Dow Jones2026/11/09 15:05Ionis Pharmaceuticals, Inc. (IONS) is currently at $29.17, down $10.25 or 26%
--Would be lowest close since April 23, 2025, when it closed at $29.10
--On pace for largest percent decrease since May 26, 2016, when it fell 39.42%
--Currently down seven of the past eight days
--Down 32.97% month-to-date
--Down 63.13% year-to-date; on pace for worst year since 2002, when it fell 70.3%
--Down 66.28% from its all-time closing high of $86.50 on Feb. 6, 2026
--Down 58.05% from 52 weeks ago (Nov. 10, 2025), when it closed at $69.54
--Down 66.28% from its 52-week closing high of $86.50 on Feb. 6, 2026
--Would be a new 52-week closing low
--Traded as low as $28.05; lowest intraday level since April 21, 2025, when it hit $27.90
--Down 28.84% at today's intraday low; largest intraday percent decrease since May 26, 2016, when it fell as much as 40.19%
All data as of 10:02:37 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 09, 2026 10:05 ET (15:05 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
HIVE’s Bitcoin output jumps 49%, but mining revenue still falls
Asia-Pacific stock markets follow the overnight rally in US tech stocks, with South Korea's KOSPI up 5% at the open, SK Hynix surging more than 7%, and Nikkei 225 rising over 2%.
This round of rebound occurred after the market experienced severe turbulence. Last week, concerns over the potential for stricter regulation of the artificial intelligence industry, due to the US Congressional election results, triggered a large-scale sell-off in chip stocks. Several market participants believe that this rebound indicates investors have not abandoned the AI trading narrative, and last week’s sell-off was more about position adjustments rather than a trend reversal.
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
